| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid Peptides | 17 | 2024 | 17 | 3.140 |
Why?
|
| Receptors, Opioid | 22 | 2024 | 26 | 2.890 |
Why?
|
| Pain | 4 | 2021 | 258 | 1.590 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2024 | 41 | 1.510 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2020 | 69 | 1.400 |
Why?
|
| Analgesics, Opioid | 7 | 2024 | 117 | 1.340 |
Why?
|
| Receptors, Opioid, mu | 16 | 2005 | 22 | 1.290 |
Why?
|
| Narcotic Antagonists | 6 | 2016 | 32 | 1.140 |
Why?
|
| Analgesia | 4 | 2021 | 13 | 0.940 |
Why?
|
| Morphine | 10 | 2012 | 29 | 0.780 |
Why?
|
| Laboratory Personnel | 1 | 2021 | 1 | 0.710 |
Why?
|
| Headache | 1 | 2020 | 34 | 0.670 |
Why?
|
| Pain Management | 1 | 2021 | 62 | 0.660 |
Why?
|
| Physicians | 1 | 2021 | 83 | 0.660 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 5 | 2007 | 5 | 0.660 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 7 | 2005 | 8 | 0.590 |
Why?
|
| Oligonucleotides, Antisense | 7 | 2000 | 22 | 0.580 |
Why?
|
| Tumor Cells, Cultured | 14 | 2004 | 314 | 0.580 |
Why?
|
| Stress, Psychological | 1 | 2020 | 229 | 0.560 |
Why?
|
| GTP-Binding Proteins | 6 | 2003 | 46 | 0.540 |
Why?
|
| Quality of Life | 1 | 2021 | 504 | 0.540 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 1494 | 0.530 |
Why?
|
| Brain | 6 | 2016 | 753 | 0.530 |
Why?
|
| Receptors, Adrenergic, beta-2 | 3 | 2007 | 23 | 0.530 |
Why?
|
| Animals | 38 | 2024 | 10580 | 0.530 |
Why?
|
| Epinephrine | 5 | 2007 | 37 | 0.520 |
Why?
|
| Cycloheptanes | 1 | 2016 | 4 | 0.520 |
Why?
|
| Hypoxia, Brain | 1 | 2016 | 5 | 0.520 |
Why?
|
| Rats | 12 | 2024 | 1587 | 0.510 |
Why?
|
| Piperidines | 1 | 2016 | 48 | 0.490 |
Why?
|
| Brain Concussion | 1 | 2016 | 52 | 0.490 |
Why?
|
| Blast Injuries | 1 | 2016 | 35 | 0.490 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2020 | 554 | 0.470 |
Why?
|
| Aminoquinolines | 1 | 2014 | 11 | 0.440 |
Why?
|
| Benzamides | 1 | 2014 | 34 | 0.430 |
Why?
|
| Receptors, Opioid, kappa | 8 | 2001 | 9 | 0.430 |
Why?
|
| Receptors, Opioid, delta | 8 | 2000 | 9 | 0.430 |
Why?
|
| Anxiety | 1 | 2014 | 157 | 0.390 |
Why?
|
| Neuroblastoma | 8 | 2003 | 56 | 0.390 |
Why?
|
| Enzyme Activation | 2 | 2011 | 267 | 0.390 |
Why?
|
| Signal Transduction | 6 | 2006 | 1454 | 0.380 |
Why?
|
| Up-Regulation | 3 | 2007 | 247 | 0.380 |
Why?
|
| Hyperalgesia | 3 | 2020 | 16 | 0.380 |
Why?
|
| Neuroimmunomodulation | 1 | 2011 | 5 | 0.350 |
Why?
|
| Naloxone | 7 | 2001 | 19 | 0.350 |
Why?
|
| NF-kappa B | 1 | 2011 | 191 | 0.330 |
Why?
|
| Spinal Cord | 1 | 2012 | 211 | 0.320 |
Why?
|
| Cyclic AMP | 9 | 2007 | 87 | 0.310 |
Why?
|
| Adenylyl Cyclases | 5 | 2003 | 14 | 0.310 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2007 | 94 | 0.300 |
Why?
|
| Receptor Cross-Talk | 3 | 2003 | 11 | 0.300 |
Why?
|
| Radioligand Assay | 6 | 2006 | 17 | 0.290 |
Why?
|
| Humans | 23 | 2021 | 28581 | 0.270 |
Why?
|
| G-Protein-Coupled Receptor Kinase 3 | 7 | 2007 | 8 | 0.260 |
Why?
|
| Cell Membrane | 7 | 2007 | 259 | 0.260 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 3 | 2002 | 4 | 0.260 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2004 | 34 | 0.250 |
Why?
|
| RNA, Messenger | 3 | 2024 | 667 | 0.250 |
Why?
|
| Male | 16 | 2020 | 13771 | 0.240 |
Why?
|
| beta-Adrenergic Receptor Kinases | 5 | 2007 | 7 | 0.240 |
Why?
|
| Synapses | 2 | 2006 | 54 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 3 | 2002 | 154 | 0.230 |
Why?
|
| Periaqueductal Gray | 3 | 2014 | 5 | 0.210 |
Why?
|
| Retina | 3 | 2006 | 437 | 0.210 |
Why?
|
| Morphine Dependence | 1 | 2002 | 2 | 0.200 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 7 | 0.200 |
Why?
|
| Naltrexone | 2 | 2000 | 19 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2005 | 611 | 0.190 |
Why?
|
| Transfection | 5 | 2011 | 319 | 0.180 |
Why?
|
| Morbidity | 1 | 2021 | 58 | 0.180 |
Why?
|
| History, 21st Century | 1 | 2021 | 49 | 0.170 |
Why?
|
| Binding, Competitive | 9 | 2003 | 62 | 0.170 |
Why?
|
| History, 20th Century | 1 | 2021 | 84 | 0.170 |
Why?
|
| Blotting, Western | 8 | 2011 | 515 | 0.170 |
Why?
|
| Nitroprusside | 1 | 2020 | 8 | 0.170 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 21 | 0.170 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2001 | 67 | 0.160 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2000 | 5 | 0.160 |
Why?
|
| Cell Line | 6 | 2011 | 698 | 0.160 |
Why?
|
| Membrane Proteins | 3 | 2002 | 485 | 0.160 |
Why?
|
| Cloning, Molecular | 3 | 1995 | 208 | 0.150 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 782 | 0.150 |
Why?
|
| Adrenergic alpha-Agonists | 3 | 2007 | 9 | 0.140 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 3 | 2007 | 10 | 0.140 |
Why?
|
| Brain Neoplasms | 2 | 2000 | 311 | 0.140 |
Why?
|
| Ambystoma | 3 | 2002 | 16 | 0.130 |
Why?
|
| Morphine Derivatives | 4 | 2000 | 5 | 0.130 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 52 | 0.130 |
Why?
|
| Down-Regulation | 3 | 2006 | 200 | 0.130 |
Why?
|
| Proteome | 1 | 2016 | 78 | 0.120 |
Why?
|
| Kinetics | 4 | 2012 | 551 | 0.120 |
Why?
|
| Peptide Mapping | 1 | 1995 | 22 | 0.120 |
Why?
|
| Motor Activity | 1 | 2016 | 148 | 0.120 |
Why?
|
| Cell Line, Tumor | 4 | 2007 | 1338 | 0.120 |
Why?
|
| Binding Sites | 6 | 2001 | 354 | 0.120 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2007 | 20 | 0.110 |
Why?
|
| Sex Characteristics | 2 | 2012 | 172 | 0.110 |
Why?
|
| Magnesium | 2 | 1993 | 42 | 0.110 |
Why?
|
| Hot Temperature | 1 | 2014 | 87 | 0.100 |
Why?
|
| Amygdala | 1 | 2014 | 52 | 0.100 |
Why?
|
| Enzyme Inhibitors | 3 | 2007 | 251 | 0.100 |
Why?
|
| Ligands | 2 | 2013 | 178 | 0.100 |
Why?
|
| Norepinephrine | 3 | 2007 | 32 | 0.100 |
Why?
|
| Neurons | 3 | 2007 | 291 | 0.100 |
Why?
|
| Drug Tolerance | 2 | 2012 | 37 | 0.100 |
Why?
|
| Hippocampus | 1 | 2014 | 194 | 0.100 |
Why?
|
| Reaction Time | 2 | 2012 | 95 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2005 | 581 | 0.100 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2012 | 8 | 0.100 |
Why?
|
| Pain Measurement | 2 | 2012 | 172 | 0.090 |
Why?
|
| Radioimmunoassay | 1 | 2012 | 45 | 0.090 |
Why?
|
| Posterior Horn Cells | 1 | 2012 | 10 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2002 | 87 | 0.090 |
Why?
|
| Base Sequence | 5 | 1996 | 588 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 1995 | 633 | 0.090 |
Why?
|
| Hydroxyquinolines | 2 | 1989 | 3 | 0.090 |
Why?
|
| Rats, Wistar | 1 | 2012 | 153 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 2012 | 51 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 1989 | 24 | 0.090 |
Why?
|
| Quinolones | 2 | 1989 | 22 | 0.090 |
Why?
|
| Mice | 9 | 2006 | 4732 | 0.090 |
Why?
|
| Narcotics | 3 | 2000 | 11 | 0.090 |
Why?
|
| Molecular Sequence Data | 5 | 1996 | 1056 | 0.090 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 50 | 0.090 |
Why?
|
| Propranolol | 2 | 2007 | 39 | 0.090 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 2 | 2007 | 7 | 0.090 |
Why?
|
| Colforsin | 3 | 2003 | 12 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2011 | 138 | 0.080 |
Why?
|
| Enkephalins | 5 | 1996 | 6 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2002 | 523 | 0.070 |
Why?
|
| Brimonidine Tartrate | 1 | 2007 | 2 | 0.070 |
Why?
|
| Adrenergic beta-2 Receptor Antagonists | 1 | 2007 | 4 | 0.070 |
Why?
|
| Quinoxalines | 1 | 2007 | 17 | 0.070 |
Why?
|
| Myocardium | 1 | 1989 | 194 | 0.070 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 2 | 2007 | 4 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 23 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 22 | 0.070 |
Why?
|
| Benzophenanthridines | 2 | 2007 | 8 | 0.070 |
Why?
|
| Alkaloids | 2 | 2007 | 16 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2006 | 465 | 0.060 |
Why?
|
| Qa-SNARE Proteins | 1 | 2006 | 7 | 0.060 |
Why?
|
| Cattle | 5 | 1996 | 388 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 104 | 0.060 |
Why?
|
| R-SNARE Proteins | 2 | 2002 | 5 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2002 | 391 | 0.050 |
Why?
|
| Tritium | 2 | 1994 | 17 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 1996 | 333 | 0.050 |
Why?
|
| Adenylyl Cyclase Inhibitors | 1 | 2003 | 2 | 0.050 |
Why?
|
| Stimulation, Chemical | 1 | 2003 | 32 | 0.050 |
Why?
|
| Octamer Transcription Factor-2 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Catecholamines | 1 | 2002 | 18 | 0.050 |
Why?
|
| Flavonoids | 1 | 2002 | 32 | 0.050 |
Why?
|
| Phenanthridines | 1 | 2002 | 12 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 31 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2002 | 79 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2002 | 74 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2002 | 12 | 0.050 |
Why?
|
| Presynaptic Terminals | 1 | 2002 | 22 | 0.050 |
Why?
|
| Photoreceptor Cells | 1 | 2002 | 36 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2003 | 151 | 0.050 |
Why?
|
| Guinea Pigs | 4 | 1996 | 73 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2002 | 273 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2002 | 419 | 0.040 |
Why?
|
| Nerve Endings | 1 | 2001 | 6 | 0.040 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2001 | 2 | 0.040 |
Why?
|
| Larva | 1 | 2001 | 28 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2001 | 22 | 0.040 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 3 | 1996 | 3 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2001 | 124 | 0.040 |
Why?
|
| Eating | 1 | 2000 | 70 | 0.040 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 18 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2000 | 23 | 0.040 |
Why?
|
| Analgesics | 2 | 1996 | 38 | 0.040 |
Why?
|
| Corpus Striatum | 4 | 1994 | 23 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1995 | 46 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 1996 | 61 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 490 | 0.040 |
Why?
|
| Enkephalin, Leucine-2-Alanine | 2 | 1995 | 3 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 695 | 0.030 |
Why?
|
| Pentazocine | 1 | 1996 | 1 | 0.030 |
Why?
|
| Receptors, sigma | 1 | 1996 | 5 | 0.030 |
Why?
|
| Forecasting | 1 | 1997 | 76 | 0.030 |
Why?
|
| Female | 2 | 2012 | 15471 | 0.030 |
Why?
|
| Drug Stability | 1 | 1995 | 23 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 18 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 77 | 0.030 |
Why?
|
| Adrenergic Agonists | 2 | 2006 | 6 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2002 | 1009 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1994 | 78 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1994 | 97 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2006 | 119 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 415 | 0.030 |
Why?
|
| Protein Conformation | 1 | 1993 | 257 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 1990 | 242 | 0.020 |
Why?
|
| Isoproterenol | 2 | 1989 | 23 | 0.020 |
Why?
|
| Reticulocytes | 2 | 1989 | 41 | 0.020 |
Why?
|
| Affinity Labels | 1 | 1991 | 4 | 0.020 |
Why?
|
| Photochemistry | 1 | 1991 | 10 | 0.020 |
Why?
|
| Food Deprivation | 1 | 1990 | 11 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1991 | 122 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1991 | 40 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2007 | 66 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 1990 | 103 | 0.020 |
Why?
|
| Pindolol | 1 | 1989 | 2 | 0.020 |
Why?
|
| Iodocyanopindolol | 1 | 1989 | 2 | 0.020 |
Why?
|
| Nadolol | 1 | 1989 | 3 | 0.020 |
Why?
|
| Glucose | 1 | 1990 | 207 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 1989 | 64 | 0.020 |
Why?
|
| Synaptosomes | 1 | 1988 | 9 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 1989 | 50 | 0.020 |
Why?
|
| Heart | 1 | 1989 | 224 | 0.020 |
Why?
|
| Phentolamine | 1 | 2007 | 2 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2007 | 6 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 114 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 328 | 0.020 |
Why?
|
| Rats, Inbred Strains | 3 | 1991 | 63 | 0.020 |
Why?
|
| Protein Transport | 1 | 2006 | 158 | 0.010 |
Why?
|
| Gene Expression | 1 | 2006 | 417 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 664 | 0.010 |
Why?
|
| Time Factors | 2 | 2002 | 1600 | 0.010 |
Why?
|
| Synapsins | 1 | 2002 | 2 | 0.010 |
Why?
|
| Synaptophysin | 1 | 2002 | 3 | 0.010 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2002 | 4 | 0.010 |
Why?
|
| Pseudopodia | 1 | 2002 | 7 | 0.010 |
Why?
|
| Synaptic Vesicles | 1 | 2002 | 17 | 0.010 |
Why?
|
| Neurites | 1 | 2002 | 10 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1601 | 0.010 |
Why?
|
| Injections, Intraventricular | 2 | 1991 | 7 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 127 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 147 | 0.010 |
Why?
|
| Bicuculline | 1 | 2000 | 4 | 0.010 |
Why?
|
| GABA Antagonists | 1 | 2000 | 4 | 0.010 |
Why?
|
| Muscimol | 1 | 2000 | 8 | 0.010 |
Why?
|
| Pyridazines | 1 | 2000 | 8 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2000 | 50 | 0.010 |
Why?
|
| Age Factors | 1 | 2002 | 734 | 0.010 |
Why?
|
| Body Weight | 1 | 2000 | 250 | 0.010 |
Why?
|
| CHO Cells | 1 | 1997 | 96 | 0.010 |
Why?
|
| Cricetinae | 1 | 1997 | 131 | 0.010 |
Why?
|
| Guanylyl Imidodiphosphate | 1 | 1996 | 2 | 0.010 |
Why?
|
| Haloperidol | 1 | 1996 | 8 | 0.010 |
Why?
|
| Carbachol | 1 | 1996 | 18 | 0.010 |
Why?
|
| Trypsin | 1 | 1996 | 24 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1996 | 25 | 0.010 |
Why?
|
| Microinjections | 1 | 1995 | 14 | 0.010 |
Why?
|
| Diprenorphine | 1 | 1995 | 1 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 27 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1996 | 257 | 0.010 |
Why?
|
| Tretinoin | 1 | 1995 | 17 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 133 | 0.010 |
Why?
|
| Thalamus | 1 | 1994 | 26 | 0.010 |
Why?
|
| Bufo marinus | 1 | 1994 | 1 | 0.010 |
Why?
|
| Goldfish | 1 | 1994 | 4 | 0.010 |
Why?
|
| Enkephalin, Leucine | 1 | 1991 | 1 | 0.010 |
Why?
|
| Seminal Vesicles | 1 | 1991 | 5 | 0.010 |
Why?
|
| Sensory Thresholds | 1 | 1991 | 14 | 0.010 |
Why?
|
| Uterus | 1 | 1991 | 31 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1990 | 29 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 1990 | 26 | 0.010 |
Why?
|
| Manganese | 1 | 1990 | 24 | 0.010 |
Why?
|
| Gastrointestinal Motility | 1 | 1989 | 30 | 0.000 |
Why?
|
| Calcium | 1 | 1990 | 243 | 0.000 |
Why?
|
| Alprenolol | 1 | 1988 | 1 | 0.000 |
Why?
|
| Cycloheximide | 1 | 1988 | 10 | 0.000 |
Why?
|
| Leucine | 1 | 1988 | 20 | 0.000 |
Why?
|
| Dopamine | 1 | 1988 | 22 | 0.000 |
Why?
|
| Membranes | 1 | 1987 | 8 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1988 | 136 | 0.000 |
Why?
|